Pengpeng Li, Ph.D.

Pengpeng Li is a Vice President with Lilly Asia Ventures (LAV) since 2022 focusing on biotech investments. Prior to joining LAV, Pengpeng was at 5AM Ventures focusing on company creation and early-stage biotech investments.



Pengpeng holds a Ph.D. in Neuroscience from Stanford University and B.S. in Biology from Peking University.